a year ago
SRPT
AnalystsMitchell KapoorMitchell Kapoor's Stock Forecasts
AnalystsMitchell Kapoor
Sectors:
Industries:
Analyst Ranking
Bottom 10%
#4651 out of 5156 analysts
Average Return
-0.38%
Win Rate
41%130 out of 320
Risk vs Reward
Poor
Good
Mitchell Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lexeo Therapeutics IncLXEO | +400.55% | $1.82 | $9.11 | 2025-04-07 - 2025-12-17 | Buy |
Instil Bio IncTIL | +363.14% | $6.81 | $31.54 | 2023-11-13 - 2024-11-13 | Buy |
Avalo Therapeutics IncAVTX | +342.53% | $4.35 | $19.25 | 2025-06-01 - 2025-12-17 | Buy |
Alumis IncALMS | +196.36% | $3.57 | $10.58 | 2025-03-19 - 2025-12-17 | Buy |
Lexeo Therapeutics IncLXEO | +181.17% | $3.24 | $9.11 | 2025-05-15 - 2025-12-17 | Buy |
Mitchell Kapoor Analyst Color
Get additional color on Mitchell Kapoor's coverage of popular stocks
a year ago
SRPT
a year ago
SMMT
Mitchell Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crispr Therapeutics AgCRSP | 5 | Buy | $80.00 | +46.15% | Maintains | 4 months ago |
Halozyme Therapeutics IncHALO | 36 | Buy | $75.00 | +14.03% | Maintains | 4 months ago |
Ionis Pharmaceuticals IncIONS | 5 | Buy | $65.00 | -15.67% | Maintains | 5 months ago |
Alumis IncALMS | 13 | Buy | $14.00 | +32.33% | Reiterates | 5 months ago |
Korro Bio IncKRRO | 13 | Buy | $100.00 | +1,164.22% | Reiterates | 5 months ago |
Oruka Therapeutics IncORKA | 6 | Buy | $45.00 | +58.56% | Reiterates | 5 months ago |
Legend Biotech CorpLEGN | 39 | Buy | $75.00 | +250.14% | Reiterates | 5 months ago |
Tyra Biosciences IncTYRA | 20 | Buy | $30.00 | +32.74% | Reiterates | 6 months ago |
Summit Therapeutics IncSMMT | 14 | Buy | $44.00 | +158.67% | Reiterates | 6 months ago |
Sarepta Therapeutics IncSRPT | 14 | Sell | $10.00 | -52.70% | Downgrades | 6 months ago |
Lyell Immunopharma IncLYEL | 13 | Hold | $10.00 | -68.82% | Maintains | 6 months ago |
Verve Therapeutics IncVERV | 7 | Hold | $13.50 | +21.29% | Downgrades | 6 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $30.00 | +241.30% | Reiterates | 6 months ago |
Instil Bio IncTIL | 16 | Buy | $125.00 | +1,035.33% | Reiterates | 6 months ago |
Boundless Bio IncBOLD | 1 | Buy | $5.00 | +293.70% | Initiates Coverage On | 7 months ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $15.00 | -22.08% | Assumes | 7 months ago |
Kyverna Therapeutics IncKYTX | 7 | Buy | $5.00 | -27.64% | Upgrades | 7 months ago |
Cytomx Therapeutics IncCTMX | 3 | Buy | $5.00 | +21.65% | Reiterates | 7 months ago |
Lexeo Therapeutics IncLXEO | 8 | Buy | $15.00 | +64.65% | Maintains | 7 months ago |
Neurogene IncNGNE | 15 | Buy | $45.00 | +135.11% | Maintains | 7 months ago |
Editas Medicine IncEDIT | 1 | Buy | $3.00 | +26.58% | Initiates Coverage On | 8 months ago |
Cartesian Therapeutics IncRNAC | 16 | Buy | $40.00 | +438.36% | Reiterates | 8 months ago |
Metagenomi IncMGX | 9 | Buy | $7.00 | +326.83% | Maintains | 8 months ago |
Zura Bio LtdZURA | 6 | Hold | $3.00 | -29.91% | Maintains | 8 months ago |
Rani Therapeutics Holdings IncRANI | 15 | Buy | $9.00 | +533.80% | Reiterates | 8 months ago |
Century Therapeutics IncIPSC | 16 | Buy | $2.00 | +199.85% | Maintains | 8 months ago |
Abeona Therapeutics IncABEO | 2 | Buy | $15.00 | +209.28% | Reiterates | 9 months ago |
Rallybio CorpRLYB | 19 | Buy | $5.00 | +596.38% | Reiterates | 9 months ago |
Tc Biopharm PLCTCBP | 3 | Buy | $48.00 | N/A | Maintains | a year ago |
Carisma Therapeutics IncCARM | 11 | Buy | $5.00 | N/A | Maintains | a year ago |
Onkure Therapeutics IncOKUR | 4 | Hold | $15.00 | N/A | Reiterates | 2 years ago |
Rain Oncology IncRAIN2 | 2 | Buy | $19.00 | N/A | Maintains | 3 years ago |
Imago Biosciences IncIMGO | 4 | Hold | $36.00 | N/A | Downgrades | 3 years ago |
Aditxt IncADTX | 1 | Buy | $180,800,000.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.